Busting Myths Around Insulin Pumps and Type 2 Diabetes
Let’s face it, while diabetes technologies are often offered to patients with type 1 diabetes, the same options are not always given to patients with type 2 diabetes. But the paradigm is slowly shifting.
For the first time, in 2025, the American Diabetes Association’s Standards of Care recommends insulin pumps should be offered to patients with insulin-requiring type 2 diabetes.1
There are few better ways to bust persistent myths than through evidence delivered with plenty of humor. That’s exactly what Drs. Edelman and Pettus from Taking Control of Your Diabetes® do in this hilarious and brief video on the Top 5 Myths About Insulin Pumps and Type 2 Diabetes.
Omnipod® 5 to the Rescue!
Omnipod 5 is the first automated insulin delivery system (AID) to be indicated for adults with type 2 diabetes (age 18+) in the U.S.. Drs. Edelman and Pettus draw on their personal experience and the SECURE-T2D clinical study, conducted with Omnipod 5, to bust the following myths:
- Patients with type 2 diabetes need to count carbs
- Pumps are too complex for these patients
- An AID system won’t be beneficial for patients on a GLP-1s
- It’s difficult to prescribe
- Fear (of hypos, of weight gain, etc.)